Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2000
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000040758A3 Enhanced sequencing by hybridization using pools of probes
11/02/2000WO2000040590A3 Functionalised polynucleotide compound, optionally marked and method for detecting a target nucleic acid
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000033161A3 Methods to reduce variance in treatment studies using genotyping
11/02/2000WO2000028086A9 Methods and compositions for diagnostic assays
11/02/2000WO2000026417A9 Detection of negative-strand rna viruses
11/02/2000WO2000008173A9 Identification and functional characterization of a novel ribosomal s6 protein kinase
11/02/2000WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
11/02/2000EP1048740A2 Methods and probe sets for determining prostate cancer prognosis
11/02/2000EP1048739A1 Method for analyzing intracellular components
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048299A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/02/2000EP1047942A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
11/02/2000EP1047937A1 Screening method for apoptosis and necrosis
11/02/2000EP1047794A2 Method for the detection or nucleic acid of nucleic acid sequences
11/02/2000EP1047793A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
11/02/2000EP1047788A2 Metastatic breast and colon cancer regulated genes
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047777A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047710A2 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof
11/02/2000EP1047707A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
11/02/2000EP1047705A2 Nucleobase oligomers
11/02/2000EP1047703A1 A combinatorial library of moenomycin analogs and methods of producing same
11/02/2000EP1047692A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
11/02/2000EP1047453A1 Method for determining gene essentiality in a pathogen
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0822991A4 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus
11/02/2000DE19916227A1 Genotypic classification of bacteria, useful e.g. for diagnosis, based on variations in the sequence of the gyr and par genes
11/02/2000CA2643162A1 Polymer identification, compositional analysis and sequencing, based on property comparison
11/02/2000CA2390158A1 Method for immobilizing substances
11/02/2000CA2384295A1 Method for determining plasminogen activator inhibitor
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371661A1 Methods and compositions for determining latent viral load
11/02/2000CA2371253A1 Genome sequence and polypepides of pyrococcus abissy, fragment and uses thereof
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370469A1 Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity
11/02/2000CA2370426A1 Identification of modulators of the marr family proteins
11/02/2000CA2370391A1 Method for down-regulating il5 activity
11/02/2000CA2370375A1 Method and kit for indicating the level of bad breath
11/02/2000CA2370365A1 Human cell line showing stable expression of cytochromes p450
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369524A1 Nucleotide extension on a microarray of gel-immobilized primers
11/02/2000CA2369058A1 Synthetic gene for expressing active retroviral protein in eukaryotes
11/02/2000CA2367954A1 Dna molecules encoding human endothelin converting enzyme 3
11/02/2000CA2367696A1 Method of diagnosing transmissible spongiform encephalopathies
11/02/2000CA2367594A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof
11/02/2000CA2367463A1 System and method for modeling genetic, biochemical, biophysical and anatomical information
11/01/2000CN2404123Y H11 plicate unine test paper
11/01/2000CN1272218A Retentate chromatography and protein chip arrays with applications in biology and medicine
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
11/01/2000CN1271778A Process for certifying serum DNA
11/01/2000CN1271775A Plant cell identity system
10/2000
10/31/2000US6141657 Method and apparatus for identifying classifying or quantifying DNA sequences in a sample without sequencing
10/31/2000US6141573 Chemical signal-impermeable mask
10/31/2000US6140500 The new dyes are brighter and permeate cells faster than currently available red-emitting live-cell nucleic acid stains.
10/31/2000US6140496 Precursors for deoxyribonucleotides containing non-standard nucleosides
10/31/2000US6140490 Pure and non-naturally occurring rna specific rna sequence and capable of binding to c1q; identified through selex method; for drugs which suppress and activate the complement system and for diagnostic agents
10/31/2000US6140489 Compositions for sorting polynucleotides
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140473 Antibodies specific for MTS2 Polypeptide
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140464 Nonapeptides that bind a HLA-A2.1 molecule
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140126 Oligonucleotides which target untranslated regions coding a transcription factor; for treatment of cancer and inflamamation; anticarcinogenic agents; antiinflammatory agents
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140110 Apparatus for multi-zone polymerase chain reaction
10/31/2000US6140102 Enzyme with the abiltiy to produce hydrogen sulfide; for the diagnosis of cardiovascular disorders
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140080 Promoter elements conferring root-preferred gene expression
10/31/2000US6140073 Useful in the promotion of tissue repair
10/31/2000US6140069 Determining the minimum inhibitory concentration of an antibiotic for a target microorganism
10/31/2000US6140067 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
10/31/2000US6140062 Using thrombin (fiia) or activated coagulation factor x (fxa)
10/31/2000US6140061 Response regulator
10/31/2000US6140057 Determining a clastogenic signature of a sample of chromosomes by quantifying frequenciesy of first type and second different type of chromosome aberrations present in the sample, then comparing the frequencies
10/31/2000US6140055 Detecting and quantitating target nucleic acid molecules in a sample via nucleic acid amplification
10/31/2000US6140054 Multiplex genotyping using fluorescent hybridization probes
10/31/2000US6140053 Determining a sequence of a nucleic acid
10/31/2000US6140052 Diagnosing and treating cancers by determining the presence or absence in a cell of wild-type adenomatous polyposis coli (apc) or a wild-type downstream protein in the apc transcription regulatory pathway
10/31/2000US6140050 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
10/31/2000US6140049 Detection and early diagnosis of prostate cancer
10/31/2000US6140048 System using time-resolved fluorescence measurement for distinguishing between at least two different types of fluorescent groups that are bound to analyte molecules in a sample
10/31/2000US6140047 Detecting the presence of one or more alleles of an il-1b haplotype
10/31/2000US6140046 Using oligonucleotide probes
10/31/2000US6140044 Methods and devices for packaging a substrate having an array of probes fabricated on its surface are disclosed
10/31/2000US6140041 Process for detecting an enzyme within a sample using a fluorescent dye
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/31/2000US6139817 Identifying varying levels of genes essential to infectivity and growth of a pathogen through use of an expression vector system which uses a promoter that is ?off? in vitro, and turns ?on? selectively during a phase of the infection
10/31/2000US6139782 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes